Search
for
Sort by
Research 271–300 of 1000+
- DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS
- The effects of acute finasteride treatment in dopamine transporter knockout mice and MK-801-treated mice
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Hand-Foot and Stump Syndrome to Sorafenib
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- Use of hair cortisol as a biomarker for chronic stress in pregnancy
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Stereotactic Body Radiation Therapy As a Derivative of Stereotactic Radiosurgery: Clinically Independent But With Enduring Common Themes
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Severe Refractory Scarring Alopecia Associated With Combinational Use of Ficlatuzumab (AV-299) and Gefitinib
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Hemodynamic effects of minoxidil following intravenous infusions in untreated hypertensive patients.
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Hair, Hormones, and High-Risk Prostate Cancer
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- Oral minoxidil for the treatment of late alopecia in cancer survivors.
- Local Pharmacokinetics and Tolerability of Topically‐Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia
- Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital.
- Chemical hair relaxer use and its potential effect on incidence of endometrial cancer in Black women.